CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NBIX — Neurocrine Biosciences Inc
CIK 884546
SAN FRANCISCO, CA
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$118,933,291
-$1,711,845 QoQ
Shares Held
902,788
+6.1% QoQ
Ownership
0.898%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.98836936246384.ToString("F0")%
Shared 0.ToString("F0")%
None 0.011630637536165745.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,717,247 | $439,415,767 | |
| 2 | VTRS |
Viatris Inc
|
13,674,306 | $184,739,874 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
300,481 | $178,179,223 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
902,788 | $118,933,291 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,577,850 | $85,617,950 | |
| 6 | ALKS |
Alkermes plc.
|
2,236,756 | $79,091,692 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,087,679 | $62,880,891 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
657,413 | $49,864,776 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,933,291 | 902,788 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $120,645,136 | 850,632 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $116,451,807 | 829,547 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $99,259,278 | 789,715 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $85,800,493 | 775,773 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $104,089,030 | 762,557 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $86,102,869 | 747,291 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $103,596,812 | 752,501 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $100,016,549 | 725,178 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $90,497,379 | 686,835 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $70,117,537 | 623,267 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $57,045,181 | 604,933 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $59,152,158 | 584,392 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $67,607,698 | 566,039 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $57,457,060 | 540,976 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $51,956,937 | 533,001 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $48,829,593 | 520,849 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $43,403,909 | 509,615 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $47,673,791 | 497,068 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $46,679,440 | 479,649 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $45,422,557 | 467,070 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $45,482,837 | 474,521 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $45,246,357 | 470,532 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $56,422,804 | 462,482 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $39,123,109 | 452,029 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||